MOG and myeloid sarcoma: Considering that MOG antibody-associated disease (MOGAD), NMOSD and MS may share clinical, radiological and laboratory features (20), there is a possibility that patients with MOGAD or NMOSD were involved in this study, especially in the CS/IS group.